Pharmaceutical Firm to Pay Huge Fines: Bolar...
From Times Staff and Wire Reports
Pharmaceutical Firm to Pay Huge Fines: Bolar Pharmaceutical Co. agreed to plead guilty to selling adulterated and mislabeled generic medicine and to pay more than $10 million in fines. Bolar of Copiague, N.Y., said it will also admit to obstructing a Food and Drug Administration investigation and lying to investigators. A 20-count criminal information filed in Baltimore federal court charged Bolar with substituting brand-name blood pressure medicine for its own hypertension drug, triamterene-hydrochlorothiazide, during testing.
